Drug
Antimony clinical trials
Includes 8 studies of Antimony Sodium Gluconate.
- studies test it
- 13
- open now
- 0
- in phase 3
- 0
- first study started
- 2002
How studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
13 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 8
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 9
SBPharmaceutical IND, Co., LTD (4) · U.S. Army Medical Research and Development Command (2) · Case Comprehensive Cancer Center (1) · M.D. Anderson Cancer Center (1) · Sarder Patel Medical College (1) · The Cleveland Clinic (1) · Northwestern University (1) · Foundation Fader (1)
Often tested with
Tested in the same studies.
Cisplatin (1) · Dacarbazine (1) · Vinblastine (1) · Interferon alpha-2 (1) · Miltefosine (1)
Studies
Open first, then newest update. How each study uses Antimony is read from its arms, and is right about nine times in ten.
Testing it · 13
- Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 MutationsStatus unknownPhase 2First Affiliated Hospital of Jinan UniversityNCT04906031Written as Sodium stibogluconate
- Sodium Stibogluconate Treatment of LeishmaniasisCompletedPhase 2U.S. Army Medical Research and Development CommandNCT00662012Written as Sodium Stibogluconate (SSG)
- Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other CancersCompletedPhase 1Case Comprehensive Cancer CenterNCT00498979Written as sodium stibogluconate
- Use of Sodium Stibogluconate as a Treatment for LeishmaniasisCompletedPhase 1/2U.S. Army Medical Research and Development CommandNCT00657618Written as Sodium Stibogluconate (SSG)
- Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced MalignanciesCompletedPhase 1M.D. Anderson Cancer CenterNCT00629200Written as Sodium Stibogluconate
- Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or MyelomaTerminatedPhase 1The Cleveland ClinicNCT00311558Written as sodium stibogluconate
- Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic SyndromeTerminatedPhase 1Northwestern UniversityNCT01009502Written as sodium stibogluconate
- Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in IndiaCompletedPhase 4Sarder Patel Medical CollegeNCT01661296Written as Sodium stibogluconate
- Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and AntimonyTerminatedPhase 2Foundation FaderNCT01380301Written as Miltefosine and antimony
- Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC)Status unknownPhase 2SBPharmaceutical IND, Co., LTDNCT01308645Written as SB injection
- Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal CancerStatus unknownPhase 2SBPharmaceutical IND, Co., LTDNCT01305980Written as SB injection
- Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung CancerStatus unknownPhase 2SBPharmaceutical IND, Co., LTDNCT01305967Written as SB injection
- Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric CancerStatus unknownPhase 2SBPharmaceutical IND, Co., LTDNCT01305993Written as SB injection
As the comparator · 9 — what is tested is compared with Antimony
- Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)Not yet recruitingPhase 3Institute of Tropical Medicine, BelgiumNCT07463040Written as Sodium Stibogluconate (SSG)
- Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium StibogluconateRecruitingPhase 2Al-Mustafa University CollegeNCT06798402Written as sodium stibogluconate (Pentostam)
- Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous LeishmaniasisRecruitingPhase 3Zagazig UniversityNCT05708625Written as Intralesional Sodium stibogluconate
- LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept StudyCompletedPhase 2Drugs for Neglected DiseasesNCT05957978Written as sodium stibogluconate
- Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern AfricaCompletedPhase 3Drugs for Neglected DiseasesNCT03129646Written as Sodium stibogluconate
- Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous LeishmaniasisCompletedPhase 2U.S. Army Medical Research and Development CommandNCT00884377Written as Sodium stibogluconate (Pentostam)
- Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V LeishmaniasisCompletedPhase 3Drugs for Neglected DiseasesNCT00255567Written as Sodium Stibogluconate
- A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous LeishmaniasisCompletedPhase 2Access to Advanced Health Institute (AAHI)NCT01011309Written as Sodium stibogluconate
- Rationales for Wound Care Management in Old World Cutaneous Leishmaniasis PatientsCompletedPhase 2Waisenmedizin e. V. Promoting Access to Essential MedicineNCT00996463Written as Sodium Stibogluconate
Codes
What other systems call Antimony · ClinicalTrials.gg INT007007
- MeSH (NLM) D000965AntimonyConfirmed NLM, Wikidata
- UNII (FDA) 9IT35J3UV3ANTIMONYConfirmed FDA, NLM, Wikidata
- RxNorm 1311407Confirmed FDA, Wikidata
- Wikidata Q1099antimonyConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C95187AntimonyOne source FDA
- DrugBank DB13110One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000965 | Antimony | Confirmed NLM, Wikidata |
| UNII (FDA) | 9IT35J3UV3 | ANTIMONY | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1311407 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1099 | antimony | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C95187 | Antimony | One source FDA |
| DrugBank | DB13110 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.